Economics of Cancer
The Applied Research Program's Health Services and Economics Branch supports several activities relevant to the economics of cancer. These include developing data resources and methods to produce estimates of the economic burden of cancer, developing detailed estimates of and determinants of the cost of cancer prevention, screening, treatment and follow-up services, and estimating the costs of cancer treatment for patients in clinical trials. NCI-sponsored studies in these areas are described at Economics of Cancer and Cancer Trials. Data resources that can be used to support studies in these areas include the SEER-Medicare Linked Database and the Cancer Research Network (CRN).
The Cancer Prevalence & Cost of Care Projections Web site shows data for cancer prevalence estimated and projected by tumor site through 2020. The site also shows national expenditures for cancer care projected through 2020.
The Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement will improve national estimates of the burden of cancer, particularly medical care expenditures for patients of all ages. It will also increase understanding of the burden of cancer with respect to its treatment and impact on access to health care, the ability to work and participate in usual activities, health insurance, and quality of care. The NCI is collaborating with the American Cancer Society, the Centers for Disease Control and Prevention, the NIH Office of Behavioral and Social Sciences Research, LIVESTRONG, and the Agency for Healthcare Research and Quality on this project.
Last Modified: 18 Oct 2013